Spexis AG
Develops therapeutics for rare diseases, oncology, and antimicrobial resistance.
SPEX | SW
Overview
Corporate Details
- ISIN(s):
- CH0106213793
- LEI:
- 391200S8HJE1I96FIG04
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 125, 4123 Allschwil
- Website:
- https://www.polyphor.com/
- Sector:
- Manufacturing
Description
Spexis AG is a clinical-stage biopharmaceutical company focused on discovering and developing therapeutics for rare diseases and oncology. The company leverages its expertise in macrocycle technology to create novel drug candidates designed to address high unmet medical needs. Its pipeline is advanced through a strategy that includes in-house discovery, development, in-licensing, and the acquisition of promising molecules. The primary therapeutic areas of interest include rare diseases and cancer, with an additional focus on antimicrobial resistance.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-04-17 02:00 |
Spexis announces extension of moratorium, receipt of an additional payment rela…
|
English | 12.1 KB | ||
| 2024-02-08 07:15 |
Spexis announces closing of sale of preclinical antibiotics program to Basilea
|
English | 13.6 KB | ||
| 2024-02-08 01:00 |
Spexis announces closing of sale of preclinical antibiotics program to Basilea
|
English | 11.9 KB | ||
| 2024-01-15 07:15 |
Spexis announces sale of preclinical antibiotics program to Basilea
|
English | 13.9 KB | ||
| 2024-01-15 01:00 |
Spexis announces sale of preclinical antibiotics program to Basilea
|
English | 12.1 KB | ||
| 2023-12-05 07:15 |
Spexis is Granted Debt-Restructuring Moratorium
|
English | 7.3 KB | ||
| 2023-12-05 01:00 |
Spexis is Granted Debt-Restructuring Moratorium
|
English | 5.9 KB | ||
| 2023-11-29 07:15 |
Spexis Provides Update Regarding Debt-Restructuring Moratorium
|
English | 9.4 KB | ||
| 2023-11-29 01:00 |
Spexis Provides Update Regarding Debt-Restructuring Moratorium
|
English | 8.0 KB | ||
| 2023-11-08 07:15 |
Spexis to file an application for a debt-restructuring moratorium
|
English | 8.3 KB | ||
| 2023-11-08 01:00 |
Spexis to file an application for a debt-restructuring moratorium
|
English | 6.6 KB | ||
| 2023-11-01 07:20 |
Spexis Announces Changes to the Executive Committee
|
English | 8.9 KB | ||
| 2023-11-01 01:00 |
Spexis Announces Changes to the Executive Committee
|
English | 7.4 KB | ||
| 2023-11-01 01:00 |
Spexis gibt Änderungen in der Geschäftsleitung bekannt
|
German | 8.0 KB | ||
| 2023-10-06 07:30 |
Spexis to host business update conference call on October 9, 2023
|
English | 7.0 KB |
Automate Your Workflow. Get a real-time feed of all Spexis AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Spexis AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Spexis AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-21 | N/A | Executive member | Other | None | N/A |
Peer Companies
